Report Highlights
The global market for elder care technologies should grow from $5.7 billion in 2017 to $13.6 billion by 2022 at a compound annual growth rate (CAGR) of 19.2% from 2017 through 2022.
Report Includes
- 25 data tables and 15 additional tables
- An overview of the global market for long-term care and home healthcare technologies
- Analyses of global market trends with data from 2015, 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Coverage of the market for long-term care and home healthcare technologies by end user, application, and geographical region
- Discussion of how changing medical needs driven by an aging population, the necessity to cut costs in the delivery of care, and further adoption of technology and broadband connectivity by seniors will accelerate future demand for remote monitoring devices and home safety technology
- Examination of the regulatory framework that controls the introduction of new remote monitoring devices in varied long-term-care settings
- Comprehensive company profiles of leading home healthcare technology companies including Philips Healthcare, Medtronic Plc., Honeywell Life Care Solutions, Omron Healthcare, Inc., Care Innovations, St. Jude Medical, Boston Scientific Corp., Biotronik SE & Co. KG and Bosch Healthcare
Report Scope
This report focuses on the global market for long-term care and home healthcare technologies used in elder care, specifically home tele-health and safety monitoring. The report provides an updated review of elder care technologies including types and applications. This report does not include the most common assistive devices (e.g., vision, hearing and daily living aids). Instead, it focuses on information and communication technologies. The report analyzes the current trends, drivers and challenges in long term care and home healthcare in regard to elder care.
The report also covers the market for long-term care and home healthcare technologies by end user and application. The end users for long-term care and home healthcare technologies are categorized as hospitals and nursing homes, home care organization, patients and their families. The report covers market application areas, such as monitoring, skilled nursing care, education and awareness and others (palliative, hospice care, rehabilitation therapy, etc.).
The scope of the study is global. BCC analyzes each market and its application, regulatory environment, new products, advancements and market projections. Also included in the report are relevant patent analyses and comprehensive profiles of companies that lead the long-term care and home healthcare technology industry. Many of the players in this industry deal with several different technologies discussed in this report. They include Philips Healthcare (part of Koninklijke Philips N.V.), Medtronic Plc., Honeywell Life Care Solutions (part of Honeywell International), Omron Healthcare, Inc. (part of Omron Corp.), Care Innovations, St. Jude Medical, Boston Scientific, Biotronik and Bosch Healthcare.
Analyst Credentials
Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.
Report Highlights
The global market for elder-care technology products was valued at $3.7 billion in 2014. This market is expected to grow to $10.3 billion in 2020 from nearly $4.4 billion in 2015, at a compound annual growth rate (CAGR) of 18.8% from 2015 to 2020.
Report Includes
- An overview of the global market for long-term care and home healthcare technologies, with a focus on remote health-monitoring and safety-monitoring systems.
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
- Discussion of how changing medical needs driven by an aging population, the necessity to cut costs in the delivery of care, and further adoption of technology and broadband connectivity by seniors will accelerate future demand for remote monitoring devices and home safety technology.
- Examination of the regulatory framework that controls the introduction of new remote monitoring devices in varied long-term-care settings.
- Ways to increase interoperability of consumer medical products.
Report Highlights
The global market for elder-care technology products was approximately $2.7 billion in 2012. It is expected to grow to roughly $3.2 billion by 2013 and $7.2 billion by 2018 at a compound annual growth rate (CAGR) from 2013 to 2018 of 17.7%.
Report Includes
- An overview of the global market for long-term care and home healthcare technologies, with a focus on remote health-monitoring and safety-monitoring systems.
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Discussion of how changing medical needs driven by an aging population, the necessity to cut costs in the delivery of care, and further adoption of technology and broadband connectivity by seniors will accelerate future demand for remote monitoring devices and home safety technology.
- Examination of the regulatory framework that controls the introduction of new remote monitoring devices in varied long-term-care settings.
- Ways to increase interoperability of consumer medical products.
Report Highlights
-
The global market for elder-care technology products is worth approximately $2.6 billion in 2010 and should grow to about $4 billion in 2015, at a compound annual growth rate (CAGR) from 2010 to 2015 of 8.7%.
-
Safety monitoring technologies are valued at $2.3 billion in 2010 and are expected to reach $3.4 billion by 2015, a compound annual growth rate of 8.2%
-
Home telehealth technologies are worth $371 million in 2010 and are expected to increase at a compound annual growth rate (CAGR) of 11.2% to reach $631 million in 2015.
Related Reports
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Pharmacy Automation: Technologies and Global Markets
The global market for pharmacy automation is estimated to increase from $7.8 billion in 2023 to reach $12.7 billion by 2028, at a compound annual growth rate (CAGR) of 10.2% from 2023 through 2028.
Global Markets for Diabetes Therapeutics and Diagnostics
The global market for diabetes therapeutics and diagnostics is estimated to increase from $102.2 billion in 2023 to reach $132.0 billion by 2028, at a compound annual growth rate (CAGR) of 5.2% from 2023 through 2028.
Global Markets for Telemedicine Technologies
The global market for telemedicine technologies is estimated to increase from $72.4 billion in 2022 to reach $173.3 billion by 2027, with a compound annual growth rate (CAGR) of 19.1% from 2022 through 2027.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More